The Zacks Analyst Blog Highlights: Apple, Chevron, CVS Health, Reynolds American and City National
For Immediate Release
Chicago, IL – December 11, 2014 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Apple Inc. (AAPL-Free Report), Chevron Corp. (CVX-Free Report), CVS Health Corporation (CVS-Free Report), Reynolds American Inc. (RAI-Free Report) and City National Corporation (CYN-Free Report).
Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.
Here are highlights from Wednesday’s Analyst Blog:
3 Stocks for a Stronger Dollar
The dollar declined on Wednesday following fears sparked off by the political situation in Greece. Investors took profits near the end of the year as markets moved lower and capital moved into U.S. Treasury securities. This caused a drop in bond yields, which pushed the dollar lower.
This comes at a time when the dollar has been enjoying multi-year highs. The dollar has been strengthening against major currencies in recent months. The strength is most likely to prevail, helping stock investors earn from top Zacks ranked potential winners with significant business exposure within the U.S.
Multi-Year High
The dollar had touched its highest level in nearly six years following better-than-expected U.S. jobs data. Non-farm payrolls increased 321,000 in November. This is the largest single-month increase since Nov 2012 and significantly higher than expectations of an increase of 230,000.
However, the dollar declined over the next two days due to a combination of factors. A fall in global stocks following low oil prices and dismal Chinese data on Monday led to these losses along with the political situation in Greece.
Additionally, there were comments from the Atlanta and San Francisco Federal presidents that the phrase “considerable time” should continue to be used in Fed policy statements. These factors combined to cause the dollar to drop to 118.78 against the yen. At one point, the greenback had slumped to 117.9, losing in excess of 2% before recovering considerably.
But the decline is being viewed as one caused by profit-taking and the rush for a safe haven in the backdrop of dismal global factors. The fundamental view of the dollar continued to be strong, and the market was simply undergoing an adjustment after the dollar’s strong gains in October and November.
Resilient Domestic Economy
In fact, the Atlanta Fed chief added that the U.S. Central Bank should still be in a position to raise interest rates later next year. This will lead to further gains for the dollar. Both the strong dollar and better-than-expected jobs report are indications of the strength in the domestic economy. This is in sharp contrast to global weakness, which remains a cause for concern.
A strong dollar combined with low oil prices are good news for the consumer as expenditures can be easily stepped up ahead of the holiday season. Imports will also become cheaper as the domestic currency strengthen. However, exports will lose their sheen as they become costlier.
At the same time, companies conducting a large portion of their business overseas will stand to lose. This is because earnings repatriated will be converted into a smaller number of dollars.
Recently, Bespoke Investment Group undertook a comparison of stocks included in the Russell 1000 index that generate in excess of 50% of their revenues abroad with those which conduct more than 90% of their sales within the U.S. In 2014, those with higher domestic sales had gained nearly 7% through Oct 2 compared to 1.7% for those with significant international operations.
Large globally diversified companies such as Apple Inc. (AAPL-Free Report) and Chevron Corp. (CVX-Free Report) conduct 61% and 76% of their sales from countries besides the U.S. and Canada. They may stand to lose from the rising dollar. In such a situation, the attractiveness of companies that conduct most of their business within the U.S is increasing.
Our Choices
In such a scenario investors stand to benefit with companies which garner nearly all of their revenues domestically. Below we present three stocks which will gain from these trends, each of which also has a good Zacks Rank.
CVS Health Corporation (CVS-Free Report) has a distinctive business model which leverages a combination of drug store retail and pharmacy benefits management. It is expected to benefit from an aging population, and a strong dollar will be another important factor which boosts growth.
CVS Health holds a Zacks Rank #2 (Buy) and has expected earnings growth of 12.3%. The forward price-to-earnings ratio (P/E) for the current financial year (F1) is 20.31.
Reynolds American Inc. (RAI-Free Report) reportable segments comprise RJR Tobacco, American Snuff, Santa Fe and All Other. RJR Tobacco is a leading cigarette manufacturer, which operates mainly in the U.S. American Snuff is a leading smokeless tobacco product manufacturer in the U.S. Santa Fe manufactures and markets cigarettes as well as other tobacco products under the Natural American Spirit brand.
Apart from a Zacks Rank #2 (Buy), the company has current year expected earnings growth of 6.7%. It has a P/E (F1) of 19.58x.
City National Corporation (CYN-Free Report) is based in Los Angeles and offers banking, investment and trust services to small and mid-sized companies, high net worth individuals and entrepreneurs. City National operates through three segments: commercial and private banking, wealth management and other.
City National holds a Zacks Rank #2 (Buy) and has expected earnings growth of 6%. It has a P/E (F1) of 18.71x.
Despite the short-term slip, the long-term outlook for the dollar remains unchanged. Companies which conduct most of their business within the U.S. stand to gain. Given these factors, adding these stocks to your portfolio would be a prudent choice.
Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today.
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros.
Get the full Report on AAPL - FREE
Get the full Report on CVX - FREE
Get the full Report on CVS - FREE
Get the full Report on RAI - FREE
Get the full Report on CYN - FREE
Follow us on Twitter: http://twitter.com/zacksresearch
Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
http://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Read the analyst report on AAPL
Read the analyst report on CVX
Read the analyst report on CVS
Read the analyst report on RAI
Read the analyst report on CYN
Zacks Investment Research
